• Skip to main content
  • Skip to footer

Pachyonychia Congenita Project

Fighting for a cure. Connecting & helping patients. Empowering Research.

Donate
VIEW MENUMENU
  • Pachyonychia Congenita
        • What Is Pachyonychia Congenita?
          • Could I Have PC?
          • Getting Diagnosed
          • Genetics
          • Image Library
          • Glossary
          • Brochures
          • Patient Stories
        • Patient Registry (IPCRR)
          • Patient Registry Data
        • Understanding my Genetic Testing Results
          • K6a-pEDD-PC
          • K6b-pEDD-PC
          • K6c-pEDD-PC
          • K16-pEDD-PC
          • K17-pEDD-PC
          • Non-PC Palmoplantar EDDs
        • Managing and Caring For PC
          • Tips and Tools
          • Living With PC
          • PC & Children
          • Working With Medical Professionals
          • Family & Friends: How To Help
          • Video Library
  • For Professionals
        • For Professionals
          • International PC Consortium
          • Pharmaceutical Partners
          • Refer a Patient
          • Patient Registry (IPCRR)
            • Patient Registry Data
            • Non-PC Palmoplantar EDDs
          • Advocacy Partners
        • PC Research
          • Apply for a Grant
          • Awarded Grants
          • Published Research Articles
          • Clinical Trials
        • Patient Voices
          • Quality of Life
          • Patient Stories
          • Patient-Focused Drug Development Meeting
  • Ways To Give
        • Ways You Can Give
          • Donate
          • Donate Just Giving UK
          • Steady Relief Circle
          • Donor-Advised Fund
          • Giving Stock
          • Legacy Society
        • Raise Awareness
          • How You Can Help
          • Fundraising Ideas
          • Share Your Story
          • PC Advocates
          • Volunteer
        • 2025 Donor Gratitude Wall
  • News & Events
        • News
          • Current Newsletter
          • Newsletter Archives
          • Sign up for our Newsletter
        • Events
          • Patient Support Meetings
          • IPCC Meetings
          • Video Library
  • About Us
        • About PC Project
        • Medical and Scientific Advisory Board
        • Financial & Legal Information
        • Contact Us

TRPV3-pEDD (palmoplantar Epidermal Differentiation Disorder)

Also referred to as Olmsted Syndrome

ATTENTION

PC Project is partnering with ORVIDA Pharma to reach out to individuals and families affected by TRPV3 or PERP-gene variants (which cause types of Olmsted Syndrome) regarding a clinical trial for people with this specific skin condition. Click the link below to learn more.

https://www.pachyonychia.org/clinical-trial-olmsted-trpv3-perp/

Facts

  • What does TRPV3 stand for? Transient receptor potential vanilloid-3.1
  • What does the TRPV3 gene do? Encodes a channel protein mainly expressed in keratinocytes.1
  • What happens when TRPV3 becomes mutated? It is hypothesized that gain of function mutation leads to apoptosis of keratinocytes causing hyperkeratosis.1
  • Clinical significance of mutation? Palmoplantar keratoderma and periorificial keratoderma.1

About Olmsted Syndrome

Skin disease caused by TRPV3 mutations is known as Olmsted syndrome. However, not all cases of Olmsted syndrome are caused by TRPV3 mutations. Two other separate genes have been identified to cause the disease.1 Olmsted syndrome is very rare. As of 2021, there were only 38 reported cases of TRPV3-related cases.1 The disease is passed down from a parent to their offspring in an autosomal dominant inheritance pattern.2 This means that it only takes one copy of the mutated TRPV3 gene from one parent to cause Olmsted syndrome. The disease has also been shown to be passed down in an autosomal recessive manner as well as X-linked in some cases. An autosomal recessive pattern describes a disease that is passed to the offspring when two mutated copies of a gene are present, while an X-linked mutation is carried on the “X” chromosome of either parent. Genetic testing is necessary to determine whether or not an individual with symptoms of Olmsted syndrome is caused by a mutation in the TRPV3 gene.2

Symptoms of TRPV3

Signs of Olmsted syndrome typically appear at birth or early childhood. As the child begins to walk and grasp, symptoms may start. The disease slowly worsens over the lifetime of the affected individual.2 The onset of symptoms usually begins with bilateral palmoplantar keratoderma in addition to hyperkeratotic plaques affecting the skin around the mouth, eyes, ears, nose, navel, and genitals.2 The keratoderma starts on the pressure points of the affected area and then extends to most of the surface where it becomes more thickened with painful, deep fissures.2 Keratotic lesions can be painful with pressure, present with an itch sensation, and can appear to be focal or punctate. Most individuals with Olmsted syndrome have a form of hair abnormality ranging from sparse to coarse, easily broken hair, or alopecia. Many individuals also have nail involvement. Nails may be rough, rigid, and display hyperkeratosis or irregular curvatures. In some cases, individuals may even have an absence of nails. It is common for individuals diagnosed with Olmsted syndrome to present with a variety of eye lesions and inflamed lacrimal glands.2 Olmsted syndrome can present with mild to severe symptoms and every individual is different.2 Genetic testing is strongly advised to determine if phenotypic changes are due to this disease.


IPCRR Data for TRPV3


Twenty-nine (29) individuals fully enrolled in the International Pachyonychia Congenita Research Registry (IPCRR) were found not to have PC but instead carry a mutation in TRPV3 gene. Below is select data from the registry.

Plantar Keratoderma93%
Always (never goes away)93%
Sometimes (clears up at times)0%
Seldom (feet usually clear)0%
Plantar Keratoderma – Onset
Birth or less than 1 year0%
1 to 4 years old54%
5 to 14 years old46%
15 years and over0%
Plantar Pain79%
Often require medications for pain57%
Very painful, but do not use medications14%
Somewhat painful7%
Palmar Keratoderma57%
Always (never goes away)36%
Sometimes (clears up at times)7%
Seldom (hands usually clear)14%

Toenail Dystrophy29%
all 10 toenails thickened0%
7-9 toenails thickened0%
4-6 toenails thickened7%
1-3 toenails thickened21%
Toenails – Onset
Birth or less than 1 year25%
1 to 4 years old25%
5 to 14 years old25%
15 years and over25%
Fingernail Dystrophy21%
all 10 toenails thickened0%
7-9 toenails thickened0%
4-6 toenails thickened7%
1-3 toenails thickened14%
Fingernails – Onset
Birth or less than 1 year33%
1 to 4 years old33%
5 to 14 years old0%
15 years and over33%
Oral Leukokeratosis7%
Cysts0%
Follicular Hyperkeratosis0%
Natal or Prenatal Teeth0%

Data from 2022 Sample Size N=14

References

  1. Zhong W, Hu L, Cao X, et al. Genotype‒Phenotype Correlation of TRPV3-Related Olmsted Syndrome. J Invest Dermatol. 2021;141(3):545-554. doi:10.1016/j.jid.2020.06.035
  2. Duchatelet S, Hovnanian A. Olmsted syndrome: clinical, molecular and therapeutic aspects. Orphanet J Rare Dis. 2015;10:33. Published 2015 Mar 17. doi:10.1186/s13023-015-0246-5

Above photos are from individuals in the IPCRR with confirmed TRPV3 mutations.

Other Conditions With Painful PPK

Footer

PC Project logo in white
PACHYONYCHIA CONGENITA PROJECT

P.O. Box 17850
Holladay, UT 84117

info@pachyonychia.org

801-987-8758

EIN 68-0567493

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Sign up for our Newsletter

Loading

Support PC Project

There are many ways you can help improve the lives of those who suffer from Pachyonychia Congenita.

Learn More
  • Contact Us
  • About Us
  • Donate
  • Patient Registry

Copyright © 2026 PC Project. All rights reserved. Pachyonychia Congenita Project is a 501(c)(3) under federal tax guidelines. Using this site means you accept its terms as outlined in the disclaimer and privacy policy.